TCTR20240425003已完成3 期
A Comparison Between Hemodialysis and Pre-dilution High Volume Online Hemodiafiltration for The Removal of Protein-bound Uremic Toxins Using Super High-flux Dialyzers: A Randomized Prospective Crossover Equality Study
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Days 至 90 Years（—）
- 性别
- All
入选标准
- •Hemodialysis patients with dialysis vintage at King Chulalongkorn Memorial hospital for more than 3 months
- •Adequate hemodialysis by Kt/V as the recommended guideline
- •Urine output less than 100 ml/day
- •Stable hemodynamic for at least 2 weeks before entering the research
排除标准
- •Active cardiovascular disease, active severe infection
- •Severe dialyzer allergy
- •Malnutrition requiring intradialytic parenteral nutrition
- •Cirrhosis child C or decompensated cirrhosis
- •Advance stage malignancy
- •Have a chance to get living related kidney transplant within 1 year
- •Unwilling to participate the project
研究者
相似试验
已完成
不适用
A comparison of removal of therapy in hemodialysis using medium cut-off dialysisKCT0003009Yonsei University Health System, Gangnam Severance Hospital6
招募中
2 期
Comparing the efficacy of hemodialysis with super high-flux dialyzer between first use and repeated useESRD on regular hemodialysisDialyzer reuse, Super high-flux dialyzer, High-performance membrane, Hemodialysis, Middle molecule uremic toxin, Beta-2 microglobulin, Total cell volume, fiber bundle volumeTCTR20211209004The Kidney Foundation of Thailand15
已完成
不适用
Study of two types of Permanent Hemodialysis Recirculation in Fixed Tip and Split Tip Catheters in chronic renal failure patientsChronic Kidney Disease.Chronic kidney disease, stage 5IRCT2015031214333N30Kermanshah University of Medical Sciences164
进行中（未招募）
不适用
A Study in Renal Predialysis and Dialysis Patients of the Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process - NDProphylactic vaccination against infection with hepatitis B virus in renal predialysis and dialysis patientsMedDRA version: 9.1Level: LLTClassification code 10038474Term: Renal insufficiencyEUCTR2006-003650-20-ITMerck and Co Inc.276
进行中（未招募）
1 期
A Study in Renal Predialysis and Dialysis Patients of the Safety,Tolerability, and Immunogenicity of Recombinant Hepatitis BVaccine Manufactured with a Modified Process - Hepatitis B Vaccine (Recombinant) Dialysis StudyHepatitis BMedDRA version: 8.1Level: LLTClassification code 10019731Term: Hepatitis BEUCTR2006-003650-20-GBMerck & Co Inc.,276